Progress in GABAA receptor agonists for insomnia disorder
Insomnia is the most common sleep disorder in which an individual has trouble falling or staying asleep. Chronic sleep loss interferes with daily functioning and adversely affects health. The main clinical drugs for insomnia are the positive allosteric modulator of the GABA (gamma-aminobutyric acid)...
Saved in:
| Main Authors: | Weiyi Wang, Wanting Fu, Hongyan Zhu, Jing Ma, Jian Zhang, Jia Qi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1432726/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GABA dysfunction in schizophrenia: The GABAA receptor as a potential therapeutic target
by: Brandon L.M. Crotchett, et al.
Published: (2025-06-01) -
Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABAAR subsynaptic reorganization
by: Caitlyn A. Chapman, et al.
Published: (2025-07-01) -
Study of diazepam effects on Ehrlich ascites carcinoma and anxiety responses in male SHK mice
by: T. S. Kalinina, et al.
Published: (2022-05-01) -
Distinct potency of compounds targeting the T1R3 subunit in modulating the response of human sweet and umami taste receptors
by: Maiko Kawasaki, et al.
Published: (2025-07-01) -
Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery
by: Xin Qiao, et al.
Published: (2025-02-01)